167 related articles for article (PubMed ID: 20628714)
1. [Current therapy options in recurrent head and neck cancer].
Boehm A; Wichmann G; Mozet C; Dietz A
HNO; 2010 Aug; 58(8):762-9. PubMed ID: 20628714
[TBL] [Abstract][Full Text] [Related]
2. Unresectable primary and recurrent head and neck tumors: effect of hyperthermia and carboplatin--preliminary experience.
Chang P; Sapozink MD; Grunberg SM; Jozsef G; Rice DM; Formenti SC; Streeter OE
Radiology; 2000 Mar; 214(3):688-92. PubMed ID: 10715031
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.
Dornoff N; Weiß C; Rödel F; Wagenblast J; Ghanaati S; Atefeh N; Rödel C; Balermpas P
Strahlenther Onkol; 2015 Aug; 191(8):656-64. PubMed ID: 26004121
[TBL] [Abstract][Full Text] [Related]
4. The dilemma of follow-up in head and neck cancer patients.
Haas I; Hauser U; Ganzer U
Eur Arch Otorhinolaryngol; 2001 May; 258(4):177-83. PubMed ID: 11407449
[TBL] [Abstract][Full Text] [Related]
5. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
6. Survival After Distant Metastasis in Head and Neck Cancer.
Wiegand S; Zimmermann A; Wilhelm T; Werner JA
Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
[TBL] [Abstract][Full Text] [Related]
7. [Best supportive care in head and neck cancer].
Salzwimmer M
Wien Med Wochenschr; 2008; 158(9-10):278-82. PubMed ID: 18560955
[TBL] [Abstract][Full Text] [Related]
8. [Promising approaches of translational research in head and neck cancer].
Dietz A
HNO; 2011 Sep; 59(9):857-8. PubMed ID: 21892801
[No Abstract] [Full Text] [Related]
9. [Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Di Martino E; Hausmann R; Krombach GA; Nowak B; Tietze L; Gagel B; Zimny M; Westhofen M
Laryngorhinootologie; 2002 Dec; 81(12):866-74. PubMed ID: 12486624
[TBL] [Abstract][Full Text] [Related]
10. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki KI; Arai Y; Yamashita Y; Yamamoto K; Sakuma Y; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):869-874. PubMed ID: 26908193
[TBL] [Abstract][Full Text] [Related]
11. Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation.
Dagan R; Morris CG; Kirwan JM; Werning JW; Vaysberg M; Amdur RJ; Mendenhall WM
Laryngoscope; 2010 May; 120(5):945-52. PubMed ID: 20422688
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results.
Balermpas P; Keller C; Hambek M; Wagenblast J; Seitz O; Rödel C; Weiss C
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e377-83. PubMed ID: 22414284
[TBL] [Abstract][Full Text] [Related]
13. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience.
Lavertu P; Adelstein DJ; Saxton JP; Secic M; Eliachar I; Strome M; Larto MA; Wood BG
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):142-8. PubMed ID: 10037279
[TBL] [Abstract][Full Text] [Related]
14. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
16. [Systemic therapy strategies for head-neck carcinomas: current status].
Hoffmann TK
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S123-43. PubMed ID: 22456917
[TBL] [Abstract][Full Text] [Related]
17. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.
Schwartz GJ; Mehta RH; Wenig BL; Shaligram C; Portugal LG
Head Neck; 2000 Jan; 22(1):34-41. PubMed ID: 10585603
[TBL] [Abstract][Full Text] [Related]
18. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
[TBL] [Abstract][Full Text] [Related]
19. Outcome after re-irradiation of head and neck cancer patients.
Platteaux N; Dirix P; Vanstraelen B; Nuyts S
Strahlenther Onkol; 2011 Jan; 187(1):23-31. PubMed ID: 21234530
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.
Koch WM; Ridge JA; Forastiere A; Manola J
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):851-8. PubMed ID: 19770416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]